Pacific Biosciences (PACB) Jumps 6.5% Ahead of Earnings

We recently published These 10 Stocks are Winning Big. Pacific Biosciences of California, Inc. (NASDAQ:PACB) is one of the best-performing stocks on Monday.

Pacific Biosciences jumped by 6.49 percent on Monday to close at $1.64 apiece as investors began repositioning portfolios ahead of its second-quarter earnings release.

According to the company, it is scheduled to announce the results of its financial and operating highlights after market close on August 7, where investors will closely watch out for updates on its restructuring plan in a bid to reduce operating expenses by $45-$50 million by the end of the year. An investor call will be held on the same day to elaborate on the results.

In the first quarter of the year, Pacific Biosciences of California, Inc. (NASDAQ:PACB) widened its net loss by 446 percent to $426 million from $78 million in the same period last year, following a 429-percent expansion in operating loss.

Revenues amounted to $37.1 million, lower by 4.6 percent than the $38.8 million year-on-year.

While we acknowledge the potential of PACB as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an extremely cheap AI stock that is also a major beneficiary of Trump tariffs and onshoring, see our free report on the best short-term AI stock.